Midlife ladies’s well being clinic Midi Health is teaming up with digital cognitive evaluation firm Neurotrack to assist ladies decide whether or not mind fog signs are indicative of menopause or indicators of extreme cognitive impairment equivalent to early dementia.
Midi Well being clinicians will have the ability to ship sufferers a Neurotrack cognitive screening that may be accomplished on a smartphone, pill or laptop. The check takes about three minutes, whereas cognitive screenings can historically take as much as 20 minutes.
Sufferers who obtain low scores on the check will probably be referred to suppliers who can full a extra detailed analysis.
“Mind fog in menopause is tremendous frequent – 74 p.c of Midi sufferers report this symptom, as prevalent as sizzling flashes. And the excellent news is that research present there is no such thing as a proof that experiencing mind fog alerts that you’re extra prone to develop dementia now or sooner or later,” Midi Well being Chief Medical Officer Kathleen Jordan mentioned in a press release.
“For most ladies with mind fog signs, a Neurotrack screening gives reassurance, however for just a few it may assist establish early dementia – a progressive illness that advantages from early detection and early remedy.”
THE LARGER TREND
The California-based ladies’s well being startup secured $25 million in Sequence A funding in October 2023, at which period it mentioned it will use the funds to develop entry to its providers nationwide.
The funding spherical was led by Google Ventures and introduced the corporate’s whole increase to $50 million. Different traders embody Operator Collective, 25M, Felicis, Icon and Semper Virens.
Silicon Valley-based Neurotrack raised $10 million in 2022 forward of its cognitive well being answer launch.
In December, Neurotrack partnered with insurance coverage supplier Nationwide to simplify long-term care underwriting. The insurance coverage firm previously used a 20-minute phone screening, which is now shortened to a few minutes with Neurotrack’s screening course of.
